(Q37596851)

English

Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target

scientific article published on 03 October 2013

Statements

Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit